Phase 1 Trial of Recombinant Human Interleukin-1β (rhIL-1β), Carboplatin, and Etoposide in Patients with Solid Cancers: Southwest Oncology Group Study 8940 (Q33500440)

From Wikidata

Jump to navigation Jump to search

scientific article published on January 1, 1997

Language	Label	Description	Also known as
English	Phase 1 Trial of Recombinant Human Interleukin-1β (rhIL-1β), Carboplatin, and Etoposide in Patients with Solid Cancers: Southwest Oncology Group Study 8940	scientific article published on January 1, 1997

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

27 July 2017

Phase 1 Trial of Recombinant Human Interleukin-1β (rhIL-1β), Carboplatin, and Etoposide in Patients with Solid Cancers: Southwest Oncology Group Study 8940 (English)

reason for preferred rank

most precise value

1 reference

10.3109/07357909709047578

https://api.crossref.org/works/10.3109/07357909709047578

18 November 2024

Phase 1 trial of recombinant human interleukin-1 beta (rhIL-1 beta), carboplatin, and etoposide in patients with solid cancers: Southwest Oncology, Group Study 8940 (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A9316621

18 November 2024

phase I clinical trial

0 references

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

author name string

J. Rinehart

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A9316621

18 November 2024

E. Hersh

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A9316621

18 November 2024

B. Issell

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A9316621

18 November 2024

P. Triozzi

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A9316621

18 November 2024

W. Buhles

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A9316621

18 November 2024

J. Neidhart

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A9316621

18 November 2024

language of work or name

1 reference

based on heuristic

inferred from title

publication date

1 January 1997

1 reference

Europe PubMed Central

PubMed publication ID

27 July 2017

1997

1 reference

National Center for Biotechnology Information

PubMed publication ID

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=9316621

18 November 2024

full work available at URL

http://www.tandfonline.com/doi/pdf/10.3109/07357909709047578

1 reference

10.3109/07357909709047578

https://api.crossref.org/works/10.3109/07357909709047578

18 November 2024

Cancer Investigation

1 reference

Europe PubMed Central

PubMed publication ID

27 July 2017

15

1 reference

Europe PubMed Central

PubMed publication ID

27 July 2017

5

1 reference

Europe PubMed Central

PubMed publication ID

27 July 2017

403-410

1 reference

Europe PubMed Central

PubMed publication ID

27 July 2017

Interleukin-1: biology, pathophysiology, and clinical prospects

1 reference

https://api.crossref.org/works/10.3109%2F07357909709047578

21 January 2018

There is more than one interleukin 1.

1 reference

https://api.crossref.org/works/10.3109%2F07357909709047578

21 January 2018

Interleukin-1 type II receptor: a decoy target for IL-1 that is regulated by IL-4

1 reference

https://api.crossref.org/works/10.3109%2F07357909709047578

21 January 2018

The hematopoietic activities of interleukin-1.

1 reference

https://api.crossref.org/works/10.3109%2F07357909709047578

21 January 2018

Interleukin-1 and hematopoiesis

1 reference

https://api.crossref.org/works/10.3109%2F07357909709047578

21 January 2018

Transforming growth factor beta 1 selectively regulates early murine hematopoietic progenitors and inhibits the growth of IL-3-dependent myeloid leukemia cell lines

1 reference

https://api.crossref.org/works/10.3109%2F07357909709047578

21 January 2018

Negative regulators of haemopoiesis--current advances

1 reference

https://api.crossref.org/works/10.3109%2F07357909709047578

21 January 2018

Interleukin 1 alpha stimulates hemopoiesis but not tumor cell proliferation and protects mice from lethal total body irradiation

1 reference

https://api.crossref.org/works/10.3109%2F07357909709047578

21 January 2018

Synergy of interleukin 1 and granulocyte colony-stimulating factor: in vivo stimulation of stem-cell recovery and hematopoietic regeneration following 5-fluorouracil treatment of mice

1 reference

https://api.crossref.org/works/10.3109%2F07357909709047578

21 January 2018

The toxic and hematologic effects of interleukin-1 alpha administered in a phase I trial to patients with advanced malignancies

1 reference

https://api.crossref.org/works/10.3109%2F07357909709047578

21 January 2018

Preliminary report: effects of interleukin-1 on platelet counts

1 reference

https://api.crossref.org/works/10.3109%2F07357909709047578

21 January 2018

Effects of interleukin-1 alpha on carboplatin-induced thrombocytopenia in patients with recurrent ovarian cancer

1 reference

https://api.crossref.org/works/10.3109%2F07357909709047578

21 January 2018

Preventive effects of interleukin 1 beta for ACNU-induced myelosuppression in malignant brain tumors: the experimental and preliminary clinical studies.

1 reference

https://api.crossref.org/works/10.3109%2F07357909709047578

21 January 2018

Recombinant human interleukin-1 beta analogue as a regulator of hematopoiesis in patients receiving chemotherapy for urogenital cancers

1 reference

https://api.crossref.org/works/10.3109%2F07357909709047578

21 January 2018

Reduction by Granulocyte Colony-Stimulating Factor of Fever and Neutropenia Induced by Chemotherapy in Patients with Small-Cell Lung Cancer

1 reference

https://api.crossref.org/works/10.3109%2F07357909709047578

21 January 2018

Effects of type beta transforming growth factors on haematopoietic progenitor cells

15

1 reference

10.3109/07357909709047578

https://api.crossref.org/works/10.3109/07357909709047578

18 November 2024

Macrophage inflammatory proteins 1 and 2: members of a novel superfamily of cytokines.

17

1 reference

10.3109/07357909709047578

https://api.crossref.org/works/10.3109/07357909709047578

18 November 2024

Identifiers

10.3109/07357909709047578

1 reference

Europe PubMed Central

PubMed publication ID

27 July 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

27 July 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q33500440&oldid=2276436514"